Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by Noteableon Jun 15, 2024 5:24pm
88 Views
Post# 36090754

RE:RE:RE:RE:RE:Multiple thoughts.

RE:RE:RE:RE:RE:Multiple thoughts.fake news  in the "oversight.house.gov" page overseen by Far right wing Republican James Comer that Peladawn posted when trying to pass it off that the Biden family received $3.5 Million from Russian oligarch Yelena Baturina when in all fact the $3.5 million deal fell through. 

According to the Biden Impeachment proceedings recorded testimony Hunter Biden's company called Rosemont Real Estate Acquisition Fund One the only deal with the Russian oligarch Yelena Baturina  fell through in 2014 after agreeing that she would invest $3.5 million with Biden and Devon Archer’s company for a real estate deal in the Chelsea neighborhood of New York City, but never did.

https://theohiostar.com/news/road-to-hunter-bidens-burisma-riches-was-paved-in-moscow-with-effort-to-court-russian-oligarchs/jtnews/2024/03/01/
<< Previous
Bullboard Posts
Next >>